tenk.fyi

Damora Therapeutics, Inc.

DMRANasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$209.8M

878.8% YoY

EPS

$3.98

121.5% YoY

Cash

$257.6M

1717.5% YoY

FY 2025 · As of 2025-12-31